Zimmer Biomet launches PrimaGen Advanced Allograft for spinal healing

Zimmer Biomet has announced the launch of PrimaGen Advanced Allograft, a new autograft substitute for use in bone healing following spinal fusion.

The new product contains the same bone healing elements as autograft, but without the risks associated with donor site morbidity or harvest site complications.

It offers a combination of demineralised cortical bone fibres with verified osteoinductivity and cancellous bone, providing a trabecular structure for natural bony in-growth that produces optimal handling and delivery characteristics.

The material has been designed to provide all three components essential for bone growth and healing – osteoconductivity, osteoinductivity and osteogenicity – and has demonstrated this strong performance in clinical trials.

PrimaGen Advanced Allograft is indicated for use as an allogeneic bone graft substitute in the repair, replacement, reconstruction or supplementation of a recipient's tissue in musculoskeletal defects.

Adam Johnson, Zimmer Biomet's spine, dental, craniomaxillofacial and thoracic group president, said: "We are pleased to include within our spine portfolio a graft that not only has desirable handling characteristics, but is simple and convenient to use. PrimaGen Advanced Allograft recreates the gold standard, while reducing the comorbidities tied to graft harvest."

With over 20 years of experience within the medical devices market, we at Zenopa have the knowledge, skills and expertise to help find the right job for you. To find out more about the current medical device roles we have available, you can search for the latest job roles, register your details, or contact the team today.